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inessential to the term’s definition, and therefore not pertinent to
our argument. The readiness of reproduction being equated with
differentiation and market elasticity are loosely stated principles of
economics, not the definition of commodity. Reducing medical
care to the status of a commodity, the objection we find in
boutique medicine, makes the practice of medicine a purely com-
mercial transaction. Whether that transaction involves a differenti-
ated or undifferentiated good or service is ethically irrelevant to our
argument that doing so undermines medical professionalism.
Our article did not predict a 2-tiered medical system emerging
from the boutique model; we did intimate that it could result in a
2-tiered individual practice among physicians who adopt it. Our
objection to this is that it would result in physicians who engage in
boutique medicine treating the rich and poor differently, which,
Dr Gregory pointed out more than 2 centuries ago, violates
fiduciary professionalism. VIP medicine is arranged and adminis-
tered by the individual physician; the tiers are within his practice.
The easier access and closer observation he provides his premium-
fee patients necessarily means that all other patientss are receiving
less than his best efforts and attention. A multitiered medical system
follows when these individual practices grease the slope toward
normalization of socially acceptable multitiered insurance benefits,
perhaps a boutique policy for the company’s top executives and a
“standard plan” for the folks on the assembly line. The quality,
quantity, and accessibility of medical care may show a normal range
of variation consistent with skills and resources from 1 institution
or physician to another. The systemization of these variations
becomes unethical, however, when they occur within a structure
that offers the physician special incentives to stratify the quality of
care on the basis of the patient’s ability to pay, or willingness to pay
an inflated premium, as in our boutique model. Drs Akbari and
Henochowicz conclude that boutique medicine is ethically neu-
tral, with doctors merely attempting “to differentiate themselves in
the marketplace by providing perceived specialized services.”
Boutique medicine does not differentiate the physicians, it
differentiates the patients—and in so doing becomes ethically
unpalatable. Drs Akbari and Henochowicz prefer “concierge” to
“boutique” medicine. Neither of these terms of commerce reflects
the special responsibilities of the medical professional, or the
absolute trust with which every patient approaches his physician.
Drs Akbari and Henochowicz have accurately described a “com-
modity” in economic discourse; if physicians begin to associate it
with their patients, the “medical profession” will become an oxy-
moron.
James W. Jones, MD, PhD
Laurence B. McCullough, PhD
Baylor College of Medicine
Houston, Tex
Bruce W. Richman, MA
University of Missouri
Columbia, Mo
REFERENCE
1. Shipley J. Dictionary of word origins. New York: Dorset Press; 1075.
doi:10.1016/j.jvs.2004.07.018
Regarding “Standards of practice: Carotid
angioplasty and stenting”
We appreciate Ouriel et al’s commentary (J Vasc Surg 2004;
39:916-7) highlighting the quality improvement guidelines for the
performance of cervical carotid angioplasty and stent placement.1
We wish to clarify that the radiology guidelines provide a
training pathway for physicians with experience sufficient to meet
the American Heart Association requirements for peripheral vas-
cular interventions, this being prior experience of 100 diagnostic
cervicocerebral angiograms with documented acceptable indica-
tions and outcomes.1,2 In agreement with previous recommenda-
tions by the American Heart Association, regardless of the number
of angiograms in another vascular bed, each vascular bed is distinct
and 100 angiograms are necessary.2
We agree with the authors that carotid stenting is a dynamic
area. As stated in our guidelines, the document was developed on
the basis of evidence-based literature. As additional peer-reviewed
studies are published, we look forward to working with all inter-
ested specialties to refine these guidelines in order to ensure
excellence in patient care. We have long recognized the valuable
impact that multidisciplinary documents have in the improvement
of patient safety and patient care outcomes.
We agree that clinical trial data are important for evaluating
new technology. However, as noted in the commentary of Ouriel
et al., some procedures prematurely become widely accepted be-
fore convincing evidence is available. In these circumstances, a
consensus statement summarizing the available evidence-based
recommendations for treatment is valuable. For example, experi-
ence has demonstrated that while benefit seemed “intuitively
clear” for extracranial-intracranial bypass surgery for carotid and
intracranial atherosclerosis, true clinical trial data led to the demise
of this procedure.3 Additionally, for 4 decades warfarin was
“thought to be” the “maximum medical therapy” for cerebrovas-
cular disease, but it was then proven that aspirin was as good as or
better than warfarin.4,5
The Society of Interventional Radiology and the American
Society of Interventional and Therapeutic Neuroradiology are
committed to working with industry and government to ensure
that appropriately selected patients have access to this beneficial
new technology. In addition to guideline development, we will
work with other specialties to ensure future coverage by Centers
for Medicare and Medicaid Services. We look forward to working
with all those involved in carotid stenting to further develop and
evaluate this important new technology.
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Reply
It is interesting to note that there exist few differences in
opinion between the radiology and surgery groups. We have more
in common than we are at variance. The 2 specialty groups seek to
collect data on novel technology, systematically analyze the infor-
mation, and provide recommendations to governmental regula-
tory agencies. The analysis of available data does not differ substan-
tially; both specialties agree that there is now ample evidence to
recommend approval of and funding for carotid stenting in se-
lected, appropriate patients.
The 1 area of remaining contention relates to the requirement
that carotid angiography be part of the training paradigm for
stenting. The radiologists identify a minimum of 100 diagnostic
carotid angiograms prior to initiating training in carotid stenting.
By contrast, the surgical and cardiology societies believe that
experience in cerebral angiography, while a necessary prerequisite
to carotid stenting, should be much more limited. Of note, the
authors of the letter incorrectly state that the 1992 AHA training
document for peripheral angioplasty specifies 100 angiograms in
each vascular bed as a prerequisite for peripheral interventions.
Review of the AHA document reveals the following statement on
privileging: “[Training] must include performance of 100 diagnos-
tic peripheral angiograms and 50 renal and/or peripheral percuta-
neous transluminal angioplasty [sic], and for at least half of these
procedures the applicant must be primary operator.”1
The document never states that “each vascular bed is distinct,”
nor does it suggest that 100 procedures must be performed in each
bed.
At the heart of this controversy, diagnostic carotid angiogra-
phy is a procedure performed in diminishing numbers in an era
where duplex ultrasound and magnetic resonance angiography
have achieved a high level of diagnostic accuracy. Further, the skills
involved in carotid angiography represent but a small subset of
those skills necessary to safely deliver and deploy a carotid stent.
Noting these limitations, the surgeons and cardiologists now ad-
vocate a much smaller number of prerequisite carotid angiograms;
on the order of 30.
The radiology groups’ declared commitment to join in the
quest for approval and funding for carotid stenting provides opti-
mism for the near-term availability of carotid stenting in appropri-
ate candidates.
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